Request a placebo training inhaler
It’s been estimated that approximately 14-92% of respiratory patients don’t use their inhaler correctly.1 As poor inhaler technique can lead to poor outcomes,2 we provide training inhalers so that you can teach the correct technique, right from the start.
You can also access how to videos and guides on the relevant product pages, or the Patient support page.
Order placebo training inhalers directly from Chiesi below.
Please note, our placebo training inhalers can only be sent to NHS institution addresses, and we provide them for individual use only. Our placebo training inhalers are supplied only to enable you to demonstrate the correct inhaler technique to a patient.
I would like to request the following placebo training inhaler(s) from Chiesi Limited to aid with inhaler technique:
pMDI training inhalers
White pressurised metered dose inhalers (pMDI)
White generic placebo training devices that represent pMDI devices: Clenil® (beclometasone), Atimos® (formoterol) and Fostair® (beclometasone / formoterol).
Grey pressurised metered dose inhalers (pMDI)
Grey placebo training inhaler that represents our Trimbow® (beclometasone / formoterol / glycopyrronium) pMDI device.
To maximise the use of pMDI placebo inhalers, please consider utilising them alongside occlusion mouthpieces, available below:
pMDI disposable occlusion mouthpieces
Single use mouthpieces designed for use with white and grey pMDI placebo training inhalers. Prevents contamination through the pMDI mouthpiece.
DPI training inhalers
Pink and white Dry Powder Inhalers (DPI)
Pink and white placebo training inhaler to represent our Fostair® (beclometasone / formoterol) NEXThaler® device.
Grey and white Dry Powder Inhalers (DPI)
Grey and white placebo training inhaler to represent our Trimbow® (beclometasone / formoterol / glycopyrronium) NEXThaler® device.
Your details
* Mandatory fields
We will use the contact details you have provided above to arrange for the delivery of your placebo training inhaler device. We will not use your contact details to send any promotional or marketing communications unless you provide your consent for us to do so. Your contact details are handled in accordance with the ABPI Code of Practice for the Pharmaceutical Industry, the latest privacy legislation and our Privacy Policy which can be found at chiesi.uk.com or can be provided upon request.
References
-
- Chrystyn H, van der Palen J, Sharma R et al. npj Prim Care Resp Med 2017;27(22)
- Melani A, Bonavia M, Cilenti V et al. Respiratory Medicine 2011;105(6):930-938
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.